CHRISTEN THOMPSON: Open Payments
NPI 1801820956 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 17 payments from 8 companies in 2025. Trend: 2023 $482 · 2024 $138 · 2025 $351
Food & beverage: $252Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $161 |
| Novartis Pharmaceuticals Corporation | 3 | $69 |
| Incyte Corporation | 2 | $37 |
| UCB, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $17 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
| Organon LLC | 2 | $14 |
| ABBVIE INC. | 1 | $14 |
Products named: TREMFYA, Rhapsido, OPZELURA, Bimzelx, CIBINQO, Zoryve, COSENTYX, SKYRIZI.
Industry payments across CA — which companies pay providers there.
